The potential of Onconase as an early first-line preventative treatment for mesothelioma is an exciting development that we plan to investigate through clinical trials,” said Dr. Carbone.
Michelle Carbone, M.D., Ph.D. is a mesothelioma researcher whose opinion holds a lot of water throu...




This article is courtesy of Mesothelioma Reporter

Add to Google